BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 25381793)

  • 21. Clinical characteristics and outcomes of dilated phase of hypertrophic cardiomyopathy: report from the registry data in Japan.
    Goto D; Kinugawa S; Hamaguchi S; Sakakibara M; Tsuchihashi-Makaya M; Yokota T; Yamada S; Yokoshiki H; Tsutsui H;
    J Cardiol; 2013 Jan; 61(1):65-70. PubMed ID: 23078864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline fragmented QRS increases the risk of major arrhythmic events in hypertrophic cardiomyopathy: Systematic review and meta-analysis.
    Rattanawong P; Riangwiwat T; Kanitsoraphan C; Chongsathidkiet P; Kanjanahattakij N; Vutthikraivit W; Chung EH
    Ann Noninvasive Electrocardiol; 2018 Jul; 23(4):e12533. PubMed ID: 29363882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early repolarization increases the occurrence of sustained ventricular tachyarrhythmias and sudden death in the chronic phase of an acute myocardial infarction.
    Naruse Y; Tada H; Harimura Y; Ishibashi M; Noguchi Y; Sato A; Hoshi T; Sekiguchi Y; Aonuma K
    Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):626-32. PubMed ID: 24863485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of Electrocardiographic Patterns at Presentation to Predict Long-term Risk of Cardiac Death in Patients With Hypertrophic Cardiomyopathy.
    Biagini E; Pazzi C; Olivotto I; Musumeci B; Limongelli G; Boriani G; Pacileo G; Mastromarino V; Bacchi Reggiani ML; Lorenzini M; Lai F; Berardini A; Mingardi F; Rosmini S; Resciniti E; Borghi C; Autore C; Cecchi F; Rapezzi C
    Am J Cardiol; 2016 Aug; 118(3):432-9. PubMed ID: 27289293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy.
    Prinz C; Schwarz M; Ilic I; Laser KT; Lehmann R; Prinz EM; Bitter T; Vogt J; van Buuren F; Bogunovic N; Horstkotte D; Faber L
    Can J Cardiol; 2013 Mar; 29(3):358-63. PubMed ID: 22749647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
    Haghjoo M; Mohammadzadeh S; Taherpour M; Faghfurian B; Fazelifar AF; Alizadeh A; Rad MA; Sadr-Ameli MA
    Europace; 2009 May; 11(5):643-9. PubMed ID: 19164362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of Long-Term Outcome in Children with Hypertrophic Cardiomyopathy.
    Ziółkowska L; Turska-Kmieć A; Petryka J; Kawalec W
    Pediatr Cardiol; 2016 Mar; 37(3):448-58. PubMed ID: 26526335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The significance of paced electrogram fractionation in hypertrophic cardiomyopathy. A prospective study.
    Saumarez RC; Slade AK; Grace AA; Sadoul N; Camm AJ; McKenna WJ
    Circulation; 1995 Jun; 91(11):2762-8. PubMed ID: 7758182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of gender on heart failure presentation in non-obstructive hypertrophic cardiomyopathy.
    Jang JH; Shin SH; Beak YS; Ko KY; Kwon SW; Park SD; Woo SI; Kim DH; Kwan J
    Heart Vessels; 2020 Feb; 35(2):214-222. PubMed ID: 31482215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotype-positive status in patients with hypertrophic cardiomyopathy is associated with higher rates of heart failure events.
    Li Q; Gruner C; Chan RH; Care M; Siminovitch K; Williams L; Woo A; Rakowski H
    Circ Cardiovasc Genet; 2014 Aug; 7(4):416-22. PubMed ID: 24909666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fragmented QRS on twelve-lead electrocardiogram predicts arrhythmic events in patients with ischemic and nonischemic cardiomyopathy.
    Das MK; Maskoun W; Shen C; Michael MA; Suradi H; Desai M; Subbarao R; Bhakta D
    Heart Rhythm; 2010 Jan; 7(1):74-80. PubMed ID: 20129288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.
    Maron MS; Olivotto I; Betocchi S; Casey SA; Lesser JR; Losi MA; Cecchi F; Maron BJ
    N Engl J Med; 2003 Jan; 348(4):295-303. PubMed ID: 12540642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term clinical course after catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Higuchi S; Ejima K; Minami Y; Ooyabu K; Iwanami Y; Yagishita D; Shoda M; Hagiwara N
    Heart Vessels; 2019 Mar; 34(3):527-537. PubMed ID: 30255478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS
    J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertrophic cardiomyopathy in the elderly: significance of atrial fibrillation.
    Doi Y; Kitaoka H
    J Cardiol; 2001; 37 Suppl 1():133-8. PubMed ID: 11433817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution and Prognostic Significance of Fragmented QRS in Patients With Brugada Syndrome.
    Morita H; Watanabe A; Morimoto Y; Kawada S; Tachibana M; Nakagawa K; Nishii N; Ito H
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28314845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exercise hemodynamics in hypertrophic cardiomyopathy identify risk of incident heart failure but not ventricular arrhythmias or sudden cardiac death.
    Smith ED; Tome J; Mcgrath R; Kumar S; Concannon M; Day SM; Saberi S; Helms AS
    Int J Cardiol; 2019 Jan; 274():226-231. PubMed ID: 30075967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.